Tag: PHARMAC
NZ ahead of the pack in funding revolutionary HIV-prevention drug PrEP
The New Zealand AIDS Foundation applauds PHARMAC’s decision to become one of the first countries in the world to publicly fund the HIV-prevention drug Pre-Exposure Prophylaxis (PrEP) – meaning those at high risk of HIV have another way to protect themselves.
Huge breakthroughs could spell the end for HIV in New Zealand
This World AIDS Day, New Zealanders have two reasons to celebrate – a massive scientific discovery and the proposed funding of a revolutionary HIV prevention pill.
HIV Epidemic in NZ: Rise in infections for gay men a serious concern
The latest figures by the AIDS Epidemiology Group show that in 2014, 217 people were newly reported with HIV in New Zealand. When comparing the number with preceding years, this is higher than any year since 2008.